ArticleHealth affairs (Project Hope)2013
Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation.
Article in Health affairs (Project Hope), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 40 citations in OpenAlex.
- De-implementing low-value care in cancer care delivery: a systematic review.Implementation science : IS · 2022Pooled it
- Men's perspectives of prostate cancer screening: A systematic review of qualitative studies.PloS one · 2017Pooled it
- Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.Ontario health technology assessment series · 2015Pooled it
- Fee cuts for radiology and low-value imaging.International journal of health economics and management · 2025Article
- Time to de-implementation of low-value cancer screening practices: a narrative review.BMJ quality & safety · 2025Review
- Use of the prostate-specific antigen (PSA) test in the United States for men age ≥65, 1999-2015: Implications for practice interventions.Cancer reports (Hoboken, N.J.) · 2021Article
- Exnovation of Low Value Care: A Decade of Prostate-Specific Antigen Screening Practices.Journal of the American Geriatrics Society · 2019Observational
- Trends in Prostate Cancer Incidence Rates and Prevalence of Prostate Specific Antigen Screening by Socioeconomic Status and Regions in the United States, 2004 to 2013.The Journal of urology · 2018Article
- Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?European journal of epidemiology · 2017Article
- Mammography rates after the 2009 revision to the United States Preventive Services Task Force breast cancer screening recommendation.Cancer causes & control : CCC · 2017Article
- Article
- Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.Cancer · 2016Article
- Knowledge of and Attitudes Toward Evidence-Based Guidelines for and Against Clinical Preventive Services: Results from a National Survey.The Milbank quarterly · 2016Article
- Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score.Cancer medicine · 2016Article
- Multicriteria decision analysis in oncology.Health expectations : an international journal of public participation in health care and health policy · 2015Review
- Article
- Article
- Article
- A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?International braz j urol : official journal of the Brazilian Society of UrologyArticle
- Decrease in Prostate Cancer Testing Following the US Preventive Services Task Force (USPSTF) Recommendations.Journal of the American Board of Family Medicine : JABFMArticle
Corrections and comments
- Commented on by
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
Abstract
In 2008 the US Preventive Services Task Force recommended against screening men ages 75 and older for prostate cancer. Using Medicare Current Beneficiary Survey Access to Care files and linked claims, we compared trends in prostate-specific antigen (PSA) testing rates between men ages 75 and older and men ages 65-74. We estimate that the revised recommendation led to a 7.9-percentage-point decline in annual PSA testing rates over two years among men ages 75 and older. Although 42 percent of men in this age group continue to receive PSA tests, our results highlight the potential of guidelines with negative recommendations to reduce the use of low-value medical care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.